NKAIN1: A Potent Drug Target and Biomarker for Sodium and Potassium Transport

Target Name: NKAIN1

NCBI ID: G79570

NKAIN1

Other Name(s): sodium/potassium transporting ATPase interacting 1 | Protein FAM77C | NKAI1_HUMAN | Family with sequence similarity 77, member C | Sodium/potassium transporting ATPase interacting 1 | FAM77C | Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 | Na+/K+ transporting ATPase interacting 1 | family with sequence similarity 77, member C | Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1

NKAIN1: A Potent Drug Target and Biomarker for Sodium and Potassium Transport

Abstract:

NKAIN1, or sodium/potassium transporting ATPase interacting 1, is a protein that plays a crucial role in the regulation of sodium and potassium homeostasis in various organisms. The NKAIN1 gene has been identified as a potential drug target and biomarker for various diseases, including hypertension, heart failure, and neurodegenerative disorders. This article will provide an overview of NKAIN1, its function, and potential as a drug target.

Introduction:

Sodium and potassium homeostasis are essential parameters for maintaining the physiological functions of various organs and tissues in the body. The regulation of these ions is critical for maintaining proper neuronal and cardiac function, as well as maintaining the stability of the blood pressure. The sodium/potassium transporting ATPase (NKAIN) is a key protein that plays a crucial role in this regulation. It is a transmembrane protein that enables the efficient transport of sodium and potassium ions across the membrane. The NKAIN1 gene has been identified as a potential drug target and biomarker for various diseases.

Function of NKAIN1:

NKAIN1 is a member of the ATP-binding subfamily of cation transport proteins (ATP-Binding Subfamily) and is responsible for the regulation of sodium and potassium homeostasis. It is a unique protein that enables the efficient transport of these two ions across the membrane. NKAIN1 functions by using ATP to pump sodium and potassium ions into the membrane. This process is critical for maintaining the proper levels of these ions in the cell, as well as ensuring the stability of the cell's electrical potential.

NKAIN1 has been shown to play a crucial role in the regulation of various physiological processes, including neuronal excitability, neurotransmitter release, and cardiac function. It has also been shown to be involved in the regulation of blood pressure, as well as the development and progression of various diseases, including hypertension, heart failure, and neurodegenerative disorders.

Potential as a Drug Target:

The NKAIN1 gene has been identified as a potential drug target for various diseases. The regulation of sodium and potassium homeostasis by NKAIN1 is thought to be involved in the development of various physiological disorders, including hypertension, heart failure, and neurodegenerative disorders.

For example, hypertension is a condition that is characterized by an increased blood pressure. NKAIN1 has been shown to play a role in the regulation of sodium and potassium homeostasis, and it is possible that alterations in NKAIN1 function may contribute to the development of hypertension.

In addition to its role in hypertension, NKAIN1 has also been shown to be involved in the regulation of other physiological processes that are affected by sodium and potassium homeostasis, including cardiac function and neurotransmitter release. This suggests that NKAIN1 may also be a potential drug target for various neurodegenerative disorders.

Biomarker Potential:

NKAIN1 has also been identified as a potential biomarker for various diseases. The regulation of sodium and potassium homeostasis by NKAIN1 is thought to be involved in the development of various physiological disorders, including hypertension, heart failure, and neurodegenerative disorders.

For example, studies have shown that alterations in NKAIN1 function may contribute to the development of hypertension. This suggests that NKAIN1 may be a potential biomarker for hypertension and could be used as a diagnostic tool for this condition.

In addition to its potential as a drug target and biomarker, NKAIN1 is also a unique protein that plays a crucial role in the regulation of sodium and potassium homeostasis. Its function in this regulation is not yet fully understood, and further research is needed to determine its potential role in these processes.

Conclusion:

NKAIN1 is a protein that plays a crucial role in the regulation of sodium and potassium homeostasis. Its function in this regulation is not yet fully understood, but it is clear that it is involved in the regulation of various physiological processes. The NKAIN1 gene has been identified as a potential drug target and biomarker for various diseases, including hypertension, heart failure, and neurodegenerative disorders. Further research is needed to fully understand its potential role in these processes and to determine its potential as a drug target.

Protein Name: Sodium/potassium Transporting ATPase Interacting 1

The "NKAIN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NKAIN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets